Bioplastics producer Danimer Scientific has reported a 4 per cent rise in third quarter revenues to $13.4 million, primarily driven by 10 per cent growth in product sales as a result of the scale up of polyhydroxyalkanoate (PHA) production for Phase 1 of the Kentucky facility brought online in 2020. PHA-based product sales grew by…

To continue reading,
please login or subscribe